Century Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
22.70
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
6
|
|
# Buys
|
3
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.58
|
0.00
|
0.58
|
100.00%
|
|
2022-12-31
|
-0.59
|
0.00
|
0.59
|
100.00%
|
|
2022-09-30
|
-0.59
|
-0.53
|
0.06
|
10.17%
|
|
2022-06-30
|
-0.52
|
-0.54
|
-0.02
|
-3.85%
|
|
2022-03-31
|
-0.45
|
-0.66
|
-0.21
|
-46.67%
|
|
2021-12-31
|
-0.48
|
-0.24
|
0.24
|
50.00%
|
|
2021-09-30
|
-0.40
|
-0.48
|
-0.08
|
-20.00%
|
|
2021-06-30
|
-0.42
|
-1.93
|
-1.51
|
-359.52%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.73
|
|
2021-12-31
|
-5.04
|
|
2020-12-31
|
-0.95
|
|
2019-12-31
|
-0.51
|